Healthcare provider profile · identity verified

Harini Goli, MD

Family Practice · BAKERSFIELD, CA · NPI 1801234414

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	270	115
Amlodipine Besylate	Amlodipine Besylate	227	85
Lisinopril	Lisinopril	168	61
Levothyroxine Sodium	Levothyroxine Sodium	151	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	149	26
Losartan Potassium	Losartan Potassium	118	49
Ibuprofen	Ibuprofen	111	58
Tizanidine Hcl	Tizanidine Hcl	108	40
Atenolol	Atenolol	107	38
Gabapentin	Gabapentin	106	36
Hydrochlorothiazide	Hydrochlorothiazide	99	41
Famotidine	Famotidine	96	46
Alendronate Sodium	Alendronate Sodium	85	33
Albuterol Sulfate Hfa	Albuterol Sulfate	82	47
Furosemide	Furosemide	76	32
Trazodone Hcl	Trazodone Hcl	75	30
Metformin Hcl	Metformin Hcl	71	27
Metoprolol Tartrate	Metoprolol Tartrate	71	27
Simvastatin	Simvastatin	71	25
Metformin Hcl Er	Metformin Hcl	59	28
Fluticasone Propionate	Fluticasone Propionate	57	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	57	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	55	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	22
Omeprazole	Omeprazole	46	18
Lovastatin	Lovastatin	45	19
Glipizide	Glipizide	42	19
Rosuvastatin Calcium	Rosuvastatin Calcium	41	20
Montelukast Sodium	Montelukast Sodium	39	15
Triamcinolone Acetonide	Triamcinolone Acetonide	37	23
Tamsulosin Hcl	Tamsulosin Hcl	36	17
Allopurinol	Allopurinol	33	13
Carvedilol	Carvedilol	33	11
Amoxicillin	Amoxicillin	32	20
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Breyna	Budesonide/Formoterol Fumarate	29	suppressed
Jardiance	Empagliflozin	28	15
Shingrix	Varicella-Zoster Ge/As01b/Pf	28	20
Alvesco	Ciclesonide	27	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Potassium Chloride	Potassium Chloride	27	12
Tramadol Hcl	Tramadol Hcl	27	suppressed
Metoprolol Succinate	Metoprolol Succinate	26	11
Pradaxa	Dabigatran Etexilate Mesylate	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Hydrocortisone	Hydrocortisone	24	11
Hydralazine Hcl	Hydralazine Hcl	23	11
Doxycycline Monohydrate	Doxycycline Monohydrate	22	21
Glipizide Er	Glipizide	22	13
Trospium Chloride	Trospium Chloride	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Sertraline Hcl	Sertraline Hcl	20	12
Lactulose	Lactulose	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Lorazepam	Lorazepam	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Nabumetone	Nabumetone	17	suppressed
Spironolactone	Spironolactone	16	suppressed
Baclofen	Baclofen	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Humulin N	Insulin Nph Human Isophane	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	12
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Colchicine	Colchicine	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Cefadroxil	Cefadroxil	13	11
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	11	11
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	11	11
Buspirone Hcl	Buspirone Hcl	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Nystatin	Nystatin	11	suppressed
Ozempic	Semaglutide	11	suppressed
Prednisone	Prednisone	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error